According to Zhitong Finance App News, Xuantai Pharmaceutical (688247.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 283 million yuan, a year-on-year decrease of 14.75%; net profit to mother was 34.08 million yuan, a year-on-year decrease of 46.30%; after deducting non-net profit of 24.74 million yuan, a year-on-year decrease of 54.08%; and basic earnings per share were 0.08 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.